WAKAYAMA MEDICAL UNIVERSITY
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1945-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
219
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (216 trials with phase data)• Click on a phase to view related trials
Isolation Procedure vs. Conventional Procedure During Distal Pancreatectosplenectomy for Pancreatic Cancer
- Conditions
- Resectable Pancreatic Body/Tail Carcinoma
- First Posted Date
- 2020-10-23
- Last Posted Date
- 2020-10-23
- Lead Sponsor
- Wakayama Medical University
- Target Recruit Count
- 100
- Registration Number
- NCT04600063
- Locations
- 🇯🇵
Kobe University, Kobe, Hyogo, Japan
🇯🇵Nara Medical University, Kashihara, Nara, Japan
🇯🇵Kinki University, Sayama, Osaka, Japan
Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer
- Conditions
- Pancreatic Ductal AdenocarcinomaMesenteric ApproachPancreaticoduodenectomy
- First Posted Date
- 2017-10-23
- Last Posted Date
- 2017-10-24
- Lead Sponsor
- Wakayama Medical University
- Target Recruit Count
- 354
- Registration Number
- NCT03317886
- Locations
- 🇯🇵
Kyusyu University, Fukuoka, Japan
🇯🇵Kansai Medical University, Hirakata, Japan
🇯🇵Hiroshima University, Hiroshima, Japan
Pembrolizumab Plus Amurubicin in Patients With Refractory Small-cell Lung Cancer
- Conditions
- Small Cell Lung Cancer Extensive Stage
- Interventions
- First Posted Date
- 2017-08-17
- Last Posted Date
- 2020-05-19
- Lead Sponsor
- Wakayama Medical University
- Target Recruit Count
- 25
- Registration Number
- NCT03253068
- Locations
- 🇯🇵
Wakayama Medical University, Wakayama, Japan
Study of NAC of GA Therapy for Patients With BRPC
- Conditions
- Pancreatic Ductal Adenocarcinoma
- Interventions
- First Posted Date
- 2016-10-06
- Last Posted Date
- 2019-10-03
- Lead Sponsor
- Wakayama Medical University
- Target Recruit Count
- 60
- Registration Number
- NCT02926183
- Locations
- 🇯🇵
Hirosaki University, Hirosaki, Aomori, Japan
🇯🇵Kobe University, Kobe, Hyogo, Japan
🇯🇵Hyogo College of Medicine, Nishinomiya, Hyogo, Japan
Combined Resection vs. Separated Resection After Mobilization of Splenic Vein During Distal Pancreatectomy
- Conditions
- Pancreatic Neoplasms
- First Posted Date
- 2016-08-18
- Last Posted Date
- 2016-08-18
- Lead Sponsor
- Wakayama Medical University
- Target Recruit Count
- 304
- Registration Number
- NCT02871804
- Locations
- 🇯🇵
Wakayama Medical University, Wakayama, Japan
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
Gut Microbiome Metabolite HYA Shows Promise for Blood Sugar Management in Type 1 Diabetes
A novel study reveals that HYA, a gut microbiome-derived metabolite, effectively reduces post-meal blood sugar spikes in type 1 diabetes model rats through multiple mechanisms.